Durvalumab (D) ± tremelimumab (T) + platinumetoposide (EP) in extensive-stage small-cell lung cancer (ES–SCLC): RNA sequencing analysis to explore canonical markers of IO activity in CASPIAN Meeting Abstract
| Authors: | Xie, M.; Chugh, P.; O'Brien, C.; Lai, Z.; Stewart, R.; Paz-Ares, L.; Goldman, J.; Garassino, M.; Rudin, C.; Barrett, J. C.; Shrestha, Y. |
| Abstract Title: | Durvalumab (D) ± tremelimumab (T) + platinumetoposide (EP) in extensive-stage small-cell lung cancer (ES–SCLC): RNA sequencing analysis to explore canonical markers of IO activity in CASPIAN |
| Meeting Title: | 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 10 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Nov 8-12 |
| Meeting Location: | Boston, MA |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2022-11-01 |
| Start Page: | A613 |
| Language: | English |
| ACCESSION: | WOS:000919423400549 |
| DOI: | 10.1136/jitc-2022-SITC2022.0586 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract; 586 -- Source: Wos |
